Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada
Phase 3 study testing valbenazine to assess its safety and tolerability in people with Huntington's disease.
Active, not recruitingPhase 3DrugClinicalTrials.govTreatment trial
Recruiting in: Ottawa, Toronto, Vancouver, Canada
Sponsor: Neurocrine Biosciences
Preparing a short plain-English summary.